It seems likely that, since phosphate per se plays a critical role in growth plate development (30), and mineralization [31] and phosphate levels are also markedly decreased in CaR−/− mice and increased by deletion of PTH, hyperphosphatemia in the CaR−/−PTH−/− mice likely contributed to the improvement in the growth plate. The gene discussed is CASR; the disease is hyperphosphatemia.